Pseudomyxoma Peritonei — Trials

Pseudomyxoma Peritonei — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Aerospace Center Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04088786	Phase I Trial HIPEC With Nal-irinotecan	completed	Phase 1	18	Stony Brook UniversityOTHER	1	May 6, 2022	clinicaltrials
NCT01652794	Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer	completed	Phase 1	12	Case Comprehensive Cancer CenterOTHER	1	Aug 4, 2015	clinicaltrials